Literature DB >> 12061642

Development of a competitive enzyme-linked immunosorbent assay for detection of turkey coronavirus antibodies.

James S Guy1, Lynda G Smith, Jamie J Breslin, Somsak Pakpinyo.   

Abstract

A competitive enzyme-linked immunosorbent assay (cELISA) was developed for detection of turkey coronavirus (TCV) antibodies. The cELISA utilized a recombinant baculovirus (Autographa californica nuclear polyhedrosis virus)-expressed TCV nucleocapsid (N) protein and biotin-labeled TCV N protein-specific monoclonal antibody. Sensitivity and specificity of the cELISA for detection of TCV antibodies were determined by comparison with the indirect fluorescent antibody test (IFAT) with 1269 reference, experimentally derived, and field-origin sera. Sera with discordant cELISA and IFAT results were further evaluated by western immunoblot analyses. The cELISA detected antibodies specific for TCV and infectious bronchitis virus, a closely related coronavirus, but did not detect antibodies specific for other avian viruses. A high degree of concordance was observed between the cELISA and IFAT; sensitivity and specificity of the cELISA relative to IFAT were 92.9% and 96.2%, respectively. Western immunoblot analyses provided additional evidence of cELISA specificity. The findings indicate that the cELISA is a rapid, sensitive, and specific serologic test for detection of TCV antibodies in turkeys.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12061642     DOI: 10.1637/0005-2086(2002)046[0334:DOACEL]2.0.CO;2

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  6 in total

1.  Seroprevalence of turkey coronavirus in North American turkeys determined by a newly developed enzyme-linked immunosorbent assay based on recombinant antigen.

Authors:  Maged H Gomaa; Dongwan Yoo; Davor Ojkic; John R Barta
Journal:  Clin Vaccine Immunol       Date:  2008-10-29

2.  Enteric viruses in turkey enteritis.

Authors:  Naresh Jindal; Sunil K Mor; Sagar M Goyal
Journal:  Virusdisease       Date:  2014-02-19

3.  The epitope study on the SARS-CoV nucleocapsid protein.

Authors:  Shuting Li; Liang Lin; Hao Wang; Jianning Yin; Yan Ren; Zhe Zhao; Jie Wen; Cuiqi Zhou; Xumin Zhang; Xiaolei Li; Jingqiang Wang; Zhengfeng Zhou; Jinxiu Liu; Jianmin Shao; Tingting Lei; Jianqiu Fang; Ningzhi Xu; Siqi Liu
Journal:  Genomics Proteomics Bioinformatics       Date:  2003-08       Impact factor: 7.691

4.  Use of recombinant S1 spike polypeptide to develop a TCoV-specific antibody ELISA.

Authors:  Maged H Gomaa; Dongwan Yoo; Davor Ojkic; John R Barta
Journal:  Vet Microbiol       Date:  2009-04-10       Impact factor: 3.293

5.  Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43.

Authors:  Thomas Mourez; Astrid Vabret; Yang Han; Julia Dina; Loïc Legrand; Sandrine Corbet; François Freymuth
Journal:  J Virol Methods       Date:  2006-10-31       Impact factor: 2.014

6.  Expression and purification of turkey coronavirus nucleocapsid protein in Escherichia coli.

Authors:  C C Loa; T L Lin; C C Wu; T A Bryan; T Hooper; D Schrader
Journal:  J Virol Methods       Date:  2004-03-15       Impact factor: 2.014

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.